Targeting MCL1 to induce mitophagy is a potential therapeutic strategy for Alzheimer disease

Mitochondrial dysfunction is associated with the occurrence of a variety of neurodegenerative diseases, especially Alzheimer disease (AD). As a mitochondrial quality control process, mitophagy is greatly inhibited in AD; increasing evidence shows that the induction of mitophagy is an effective thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Cen, Xufeng, Xu, Xiaoyan, Xia, Hongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Autophagic Punctum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032245/
https://www.ncbi.nlm.nih.gov/pubmed/33342330
http://dx.doi.org/10.1080/15548627.2020.1860542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032245/
https://www.ncbi.nlm.nih.gov/pubmed/33342330
http://dx.doi.org/10.1080/15548627.2020.1860542

Ejemplares similares